{"id":"https://openalex.org/W4389243799","doi":"https://doi.org/10.1182/blood-2023-187198","title":"Overall Survival Following First and Second Relapse of DLBCL Treated with Therapies Including Autologous Transplant and CAR-T Cells: Results from the Lion Prospective Observational Registry","display_name":"Overall Survival Following First and Second Relapse of DLBCL Treated with Therapies Including Autologous Transplant and CAR-T Cells: Results from the Lion Prospective Observational Registry","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4389243799","doi":"https://doi.org/10.1182/blood-2023-187198"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2023-187198","doi":"https://doi.org/10.1182/blood-2023-187198","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-187198","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/6325/2188230/blood-2922-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/6325/2188230/blood-2922-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060885240","display_name":"Greg Kirkpatrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greg Kirkpatrick","raw_affiliation_strings":["1University of Iowa, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Iowa, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043541884","display_name":"Jeffrey M. Switchenko","orcid":"https://orcid.org/0000-0002-5563-9325","observed_orcids":["https://orcid.org/0000-0002-5563-9325"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey M. Switchenko","raw_affiliation_strings":["2Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060834552","display_name":"Melissa Kives","orcid":"https://orcid.org/0000-0003-0801-168X","observed_orcids":["https://orcid.org/0000-0003-0801-168X"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Kives","raw_affiliation_strings":["2Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006813053","display_name":"Katelin Baird","orcid":"https://orcid.org/0000-0003-2991-8336","observed_orcids":["https://orcid.org/0000-0003-2991-8336"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katelin Baird","raw_affiliation_strings":["3Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024389256","display_name":"Kami J. Maddocks","orcid":"https://orcid.org/0000-0001-8519-8404","observed_orcids":["https://orcid.org/0000-0001-8519-8404"]},"institutions":[{"id":"https://openalex.org/I4210109577","display_name":"Ohio State University Hospital","ror":"https://ror.org/020yh1f96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970","https://openalex.org/I4210109577"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kami J. Maddocks","raw_affiliation_strings":["4The James Cancer Center, Ohio State University Hospital, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4The James Cancer Center, Ohio State University Hospital, Columbus, OH","institution_ids":["https://openalex.org/I4210109577"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075285981","display_name":"Jason T. Romancik","orcid":"https://orcid.org/0000-0003-0054-9362","observed_orcids":["https://orcid.org/0000-0003-0054-9362"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason T. Romancik","raw_affiliation_strings":["3Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031412066","display_name":"Deborah Marie Stephens","orcid":"https://orcid.org/0000-0001-9188-5008","observed_orcids":["https://orcid.org/0000-0001-9188-5008"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah M. Stephens","raw_affiliation_strings":["5Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Huntsman Cancer Institute, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011348837","display_name":"Harsh Shah","orcid":"https://orcid.org/0000-0001-6054-5238","observed_orcids":["https://orcid.org/0000-0001-6054-5238"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harsh Shah","raw_affiliation_strings":["5Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Huntsman Cancer Institute, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101811382","display_name":"Javier A. Pinilla-Ibarz","orcid":"https://orcid.org/0000-0003-3170-9648","observed_orcids":["https://orcid.org/0000-0003-3170-9648"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Javier Pinilla-Ibarz","raw_affiliation_strings":["6H Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6H Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084789778","display_name":"Julio C. Ch\u00e1vez","orcid":"https://orcid.org/0000-0002-2045-6238","observed_orcids":["https://orcid.org/0000-0002-2045-6238"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio C Chavez","raw_affiliation_strings":["7Department of Malignant Hematology, Moffitt Cancer Center, Lutz, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Malignant Hematology, Moffitt Cancer Center, Lutz, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049461398","display_name":"Matthew J. Matasar","orcid":"https://orcid.org/0000-0002-4581-3721","observed_orcids":["https://orcid.org/0000-0002-4581-3721"]},"institutions":[{"id":"https://openalex.org/I4390039325","display_name":"Rutgers Cancer Institute","ror":"https://ror.org/0060x3y55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4390039325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Matasar","raw_affiliation_strings":["8Rutgers Cancer Institute of New Jersey, New Brunswick, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Rutgers Cancer Institute of New Jersey, New Brunswick, NJ","institution_ids":["https://openalex.org/I4390039325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023426390","display_name":"Craig Anthony Portell","orcid":"https://orcid.org/0000-0002-9487-8345","observed_orcids":["https://orcid.org/0000-0002-9487-8345"]},"institutions":[{"id":"https://openalex.org/I2799765794","display_name":"University of Virginia Health System","ror":"https://ror.org/00wn7d965","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799765794"]},{"id":"https://openalex.org/I4210134211","display_name":"University of Virginia Medical Center","ror":"https://ror.org/046kb4y45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799765794","https://openalex.org/I4210134211"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig A. Portell","raw_affiliation_strings":["9Division of Hematology and Oncology, Department of Medicine, University of Virginia Medical Center, Charlottesville, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Division of Hematology and Oncology, Department of Medicine, University of Virginia Medical Center, Charlottesville, VA","institution_ids":["https://openalex.org/I2799765794","https://openalex.org/I4210134211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057234924","display_name":"Michelle L. Churchman","orcid":"https://orcid.org/0000-0002-6560-1056","observed_orcids":["https://orcid.org/0000-0002-6560-1056"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Churchman","raw_affiliation_strings":["10ORIEN, Hudson, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10ORIEN, Hudson, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007477825","display_name":"Jonathon Brett Cohen","orcid":"https://orcid.org/0000-0002-2723-6481","observed_orcids":["https://orcid.org/0000-0002-2723-6481","https://orcid.org/0000-0001-7696-2693"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathon B. Cohen","raw_affiliation_strings":["11Winship Cancer Institute, Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Winship Cancer Institute, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100688501","display_name":"Umar Farooq","orcid":"https://orcid.org/0000-0001-7891-9891","observed_orcids":["https://orcid.org/0000-0001-7891-9891","https://orcid.org/0009-0006-5071-4070"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Umar Farooq","raw_affiliation_strings":["12University of Iowa, Iowa City"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12University of Iowa, Iowa City","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083450833","display_name":"Brian K. Link","orcid":"https://orcid.org/0000-0001-5084-0698","observed_orcids":["https://orcid.org/0000-0001-5084-0698"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian K. Link","raw_affiliation_strings":["1University of Iowa, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Iowa, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"Supplement 1","first_page":"6325","last_page":"6325"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7799999713897705},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8690000176429749},{"id":"https://openalex.org/keywords/double-hit-lymphoma","display_name":"double-hit lymphoma","score":0.9100000262260437},{"id":"https://openalex.org/keywords/polatuzumab-vedotin","display_name":"polatuzumab vedotin","score":0.8700000047683716},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.7009999752044678},{"id":"https://openalex.org/keywords/high-grade-b-cell-lymphoma","display_name":"high-grade B-cell lymphoma","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7512791156768799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6123033165931702},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5852636694908142},{"id":"https://openalex.org/C2781214270","wikidata":"https://www.wikidata.org/wiki/Q4692282","display_name":"Aggressive lymphoma","level":4,"score":0.559180498123169},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5327330231666565},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5041345357894897},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.44417721033096313},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.41832906007766724},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3900269865989685},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3678606450557709},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.3587450385093689}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2023-187198","doi":"https://doi.org/10.1182/blood-2023-187198","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-187198","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/6325/2188230/blood-2922-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2023-187198","doi":"https://doi.org/10.1182/blood-2023-187198","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-187198","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/6325/2188230/blood-2922-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320315141","display_name":"LAM Therapeutics","ror":"https://ror.org/044r4fv50"},{"id":"https://openalex.org/F4320317235","display_name":"BeiGene","ror":"https://ror.org/012v2c923"},{"id":"https://openalex.org/F4320319515","display_name":"Seagen","ror":null},{"id":"https://openalex.org/F4320328062","display_name":"MorphoSys","ror":"https://ror.org/00ew7rg06"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320333648","display_name":"Pharmacyclics","ror":"https://ror.org/03hm8w204"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389243799.pdf","grobid_xml":"https://content.openalex.org/works/W4389243799.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386209353","https://openalex.org/W4389222116","https://openalex.org/W2980762345","https://openalex.org/W2002106466","https://openalex.org/W3104600561","https://openalex.org/W4411320520","https://openalex.org/W4224324340","https://openalex.org/W2986154340","https://openalex.org/W3203427599","https://openalex.org/W2974108516"],"abstract_inverted_index":{"Background:":[0],"Diffuse":[1],"large":[2,95,113],"B":[3],"cell":[4,62,261,407,578],"lymphoma":[5,15,122],"(DLBCL)":[6],"is":[7,18,595],"the":[8,105,190,653],"most":[9],"common":[10],"subtype":[11],"of":[12,28,42,166,185,196,211,287,588,608,649],"aggressive":[13],"non-Hodgkin":[14],"(NHL)":[16],"and":[17,64,85,119,125,160,237,255,266,284,339,363,378,396,417,445,468,485,498,508,529,549,618,637,641],"curable":[19],"with":[20,57,111,123,199,252,300,307,321,348,460,477,590],"first-line":[21],"conventional":[22],"chemotherapy,":[23],"but":[24],"a":[25,40,75,94,560,585,603],"significant":[26,562],"fraction":[27],"patients":[29,102,139,179,198,569,622],"relapse":[30],"or":[31,58,170,452,656],"do":[32],"not":[33,116,427,447,644],"respond":[34],"to":[35,215,581],"initial":[36],"therapy.":[37,220],"There":[38],"are":[39],"variety":[41],"treatments":[43,246],"available":[44],"for":[45,90,293,310,317,368,374,405,434,456,488,494,514,538,606],"relapsed/refractory":[46],"(RR)":[47],"disease,":[48],"including":[49,632],"platinum-based":[50,248,273,297,311,318,369,457,489,571,624],"salvage":[51,249,274,298,312,319,370,458,490,572,609,625],"chemotherapy":[52,250,299,313,320,459,573,626],"often":[53],"used":[54],"historically":[55],"both":[56,251,483],"without":[59,256,314,371,491],"autologous":[60,259,301,322,461,576],"stem":[61,260,577],"transplant,":[63,262],"chimeric":[65],"antigen":[66],"receptor":[67],"T-cell":[68],"(CAR-T)":[69],"therapy":[70,89,277,408,516],"emerging":[71],"more":[72],"recently":[73],"as":[74,162],"second-line":[76],"option.":[77],"We":[78,100,558],"report":[79],"survival":[80,155,651],"data":[81,145],"following":[82],"2":[83,167,204,294,654],"nd":[84,168,205,295,655],"3":[86,171,217,657],"rd":[87,172,218,658],"line":[88,174,206,219,245,296,659],"RR":[91,200,591],"DLBCL":[92,201],"in":[93,226,233,240,566,568,584,598,621,652],"contemporary":[96,586],"prospective":[97],"cohort.":[98],"Methods:":[99],"selected":[101],"(pts)":[103],"from":[104,148,164,272],"Lymphoma":[106],"Innovations":[107],"ORIEN":[108],"Network":[109],"(LION)":[110],"diffuse":[112],"B-cell":[114,121],"lymphoma,":[115],"otherwise":[117],"specified":[118],"high-grade":[120],"MYC":[124],"BCL2":[126],"and/or":[127],"BCL6":[128],"rearrangements":[129],"(\u201cdouble-hit\u201d":[130],"lymphoma)":[131],"who":[132,202],"had":[133,140],"previously":[134],"received":[135,203],"R-CHOP":[136],"chemotherapy.":[137,610],"All":[138],"signed":[141],"written":[142],"consent.":[143],"Clinical":[144],"were":[146,187,208],"abstracted":[147],"medical":[149],"records":[150],"using":[151,158,189],"standardized":[152],"protocol.":[153],"Overall":[154],"was":[156,303,324,380,409,437,463,500,517,541,612],"estimated":[157],"Kaplan-Meier":[159],"defined":[161],"time":[163],"start":[165],"(OS2)":[169],"(OS3)":[173],"treatment":[175,207,288],"until":[176],"death,":[177],"censoring":[178],"alive":[180],"at":[181,329,336,344,353,360,385,393,401,414,422,430,442,450,465,473,482,505,522,534,546,554,615],"last":[182],"follow-up.":[183],"Comparisons":[184],"OS":[186],"performed":[188],"log-rank":[191,565],"test.":[192],"Results:":[193],"A":[194],"total":[195],"328":[197],"included,":[209],"177":[210],"whom":[212],"went":[213],"on":[214],"receive":[216],"Baseline":[221],"characteristics":[222],"included":[223,247],"male":[224],"sex":[225],"205":[227],"pts":[228,235,242,589],"(65%),":[229],"stage":[230],"III/IV":[231],"disease":[232],"244":[234],"(81%),":[236],"extranodal":[238],"involvement":[239],"183":[241],"(63%).":[243],"Second":[244],"(99":[253],"pts)":[254,258],"(88":[257],"rituximab":[263,375,495,638],"plus":[264,376,496,639],"gemcitabine":[265,377,497,640],"oxaliplatin":[267,379,499,642],"(30":[268],"pts,":[269],"grouped":[270],"distinctly":[271],"chemotherapy),":[275],"CAR-T":[276,406,515,633],"(43":[278],"pts),":[279,283],"polatuzumab":[280,435,539,635],"vedotin":[281,436,540],"(17":[282],"other":[285,582],"classes":[286],"(51":[289],"pts).":[290],"Median":[291],"OS2":[292,316,373,404,433,567],"transplant":[302,323,462,579,601],"110.4":[304],"months":[305,309,346,416,444,467,475,487,507,548,620],"compared":[306,347,476,580],"50.4":[308],"transplant.":[315,372,492,629],"96.5%":[325],"(95%":[326,333,341,350,357,365,382,390,398,411,419,439,470,479,502,510,519,526,531,543,551],"CI":[327,334,342,351,358,366,383,391,399,412,420,440,471,480,503,511,520,527,532,544,552],"90-99)":[328],"12":[330,354,386,415,443,466,484,506,523,547],"months,":[331,338,355,362,387,395,424,524],"90.7%":[332],"81-96)":[335],"24":[337,361,394,423,451,474,486,555],"79.3%":[340],"67-88)":[343],"60":[345,402,431,453,535,619],"77.1%":[349],"66-85)":[352],"65.5%":[356],"52-76)":[359],"38.1%":[364],"21-55)":[367],"81.7%":[381,389],"58-93)":[384,392],"still":[388],"70.1%":[397],"37-88)":[400],"months.":[403,432,454,536,556],"75%":[410,501],"50-89)":[413],"62.5%":[418],"36-80)":[421],"it":[425],"could":[426,446],"be":[428,448],"calculated":[429,449],"73.5%":[438],"36-91)":[441],"OS3":[455,493,513,537,611],"100%":[464],"83.3%":[469],"27-98)":[472],"70.7%":[478],"34-90)":[481],"13-96)":[504],"50%":[509],"6-85).":[512],"86.3%":[518],"75-93)":[521],"65.8%":[525],"50-78)":[528],"46.3%":[530],"22-68)":[533],"53.4%":[542],"24-76)":[545],"40.1%":[550],"12-67)":[553],"Conclusions:":[557],"observed":[559],"statistically":[561],"difference":[563,594],"by":[564,575,600,628],"receiving":[570,623],"followed":[574,627],"therapies":[583,631],"cohort":[587],"DLBCL.":[592],"This":[593],"likely":[596],"driven":[597],"part":[599],"being":[602],"surrogate":[604],"marker":[605],"efficacy":[607],"also":[613],"highest":[614],"12,":[616],"24,":[617],"Other":[630],"cells,":[634],"vedotin,":[636],"did":[643],"demonstrate":[645],"significantly":[646],"different":[647],"rates":[648],"overall":[650],"setting.":[660]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-12-02T00:00:00"}